Toronto Dominion Bank’s AdaptHealth AHCO Stock Holding History

Toronto Dominion Bank’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8	Closed	–	–	1296
2022 Q1	$0	Hold	8	–	–	﹤0.01%	1386
2021 Q4	$0	Buy	+8	New	+$188	﹤0.01%	1491

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Toronto Dominion Bank's AHCO Position: Q2 2022 in Review

Toronto Dominion Bank sold out of AdaptHealth (AHCO) in Q2 2022, closing a stake of 8 shares.

Toronto Dominion Bank first reported a position in AHCO in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 149 funds tracked by Wall St. Rank hold AHCO as of Q2 2022.

Toronto Dominion Bank reported no remaining AdaptHealth position as of Q2 2022 after selling out during the quarter.
Toronto Dominion Bank sold 8 AdaptHealth shares in Q2 2022.
Toronto Dominion Bank first reported a position in AdaptHealth in Q4 2021 and held it in 2 quarters.
Toronto Dominion Bank's AdaptHealth position peaked at $0 in Q1 2022.
149 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2022.

Based on Toronto Dominion Bank's 13F filing for Q2 2022, filed 11 Aug 2022.